Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Practice Point
Nature Reviews Nephrology 1, 20–21 (1 November 2005) | doi:10.1038/ncpneph0020
Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?
Abstract
Hutchison AJ et al. (2005) Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate. Nephron Clin Pract 100: c8–c19 Synopsis Background Hyperphosphatemia increases the risk of adverse outcomes in patients with end-stage renal disease.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
